(Reuters) - The drug, known generically as irbesartan/hydrochlorothiazide, is already approved to treat hypertension but not as an initial treatment.
The U.S. Food and Drug Administration staff reviewer also said post-approval action such as more study was not needed.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment